Genesys Capital
Overview
Genesys Capital is a venture capital firm focused on building companies in the high-growth sectors of life sciences . They invest in early-stage companies operating in biotechnology, pharmaceuticals, and medical technology . The firm accelerates the development of commercially viable emerging companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Specific Biologics | Nov 2026 | Series A | Co-investor |
| Questat | - | Seed | Lead |
| Flosonics Medical | Mar 2024 | Series C | Co-investor |
| Feldan Therapeutics | Feb 2025 | Strategic | Co-investor |
| Giiant Pharma Inc. | May 2021 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genesys Capital based?
Genesys Capital is headquartered in Toronto, Ontario, Canada.
When was Genesys Capital founded?
Genesys Capital was founded in 2000.
How many portfolio companies does Genesys Capital have?
Genesys Capital has 15 portfolio companies in Caplight's dataset.
What are some companies in Genesys Capital's portfolio?
Portfolio companies visible on Caplight include Specific Biologics, Questat, Flosonics Medical, Feldan Therapeutics, Giiant Pharma Inc..
What was Genesys Capital's most recent investment shown here?
Genesys Capital's most recent investment in this portfolio sample was in Specific Biologics in 2026.
What sectors does Genesys Capital focus on?
Genesys Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Genesys Capital focus on?
Genesys Capital typically invests at the MultiStage stage.
What is Genesys Capital's AUM?
Genesys Capital's assets under management are estimated between $100.0M and $250.0M.